{
    "2018-12-25": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Pfizer’s Vaccines: A Look at Their Market Performance",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "vaccines",
                        "market performance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pfizer’s Inlyta and Recent Developments in Its Oncology Business",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Inlyta",
                        "oncology",
                        "developments"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Xtandi and Bosulif Are Expected to Boost Pfizer’s Revenue Growth",
                "features": {
                    "keywords": [
                        "Xtandi",
                        "Bosulif",
                        "Pfizer",
                        "revenue growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}